206 related articles for article (PubMed ID: 8671851)
1. Synergistic renal protection by combining alkaline-diuresis with lipid peroxidation inhibitors in rhabdomyolysis: possible interaction between oxidant and non-oxidant mechanisms.
Salahudeen AK; Wang C; Bigler SA; Dai Z; Tachikawa H
Nephrol Dial Transplant; 1996 Apr; 11(4):635-42. PubMed ID: 8671851
[TBL] [Abstract][Full Text] [Related]
2. Evaluations of lipid peroxidation and inflammation in short-term glycerol-induced acute kidney injury in rats.
Nara A; Yajima D; Nagasawa S; Abe H; Hoshioka Y; Iwase H
Clin Exp Pharmacol Physiol; 2016 Nov; 43(11):1080-1086. PubMed ID: 27529136
[TBL] [Abstract][Full Text] [Related]
3. Rhabdomyolysis-Induced AKI Was Ameliorated in NLRP3 KO Mice via Alleviation of Mitochondrial Lipid Peroxidation in Renal Tubular Cells.
Song SJ; Kim SM; Lee SH; Moon JY; Hwang HS; Kim JS; Park SH; Jeong KH; Kim YG
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202867
[TBL] [Abstract][Full Text] [Related]
4. Anesthetic effects on the glycerol model of rhabdomyolysis-induced acute renal failure in rats.
Lochhead KM; Kharasch ED; Zager RA
J Am Soc Nephrol; 1998 Feb; 9(2):305-9. PubMed ID: 9527408
[TBL] [Abstract][Full Text] [Related]
5. Phenolic antioxidants tert-butyl-bisphenol and vitamin E decrease oxidative stress and enhance vascular function in an animal model of rhabdomyolysis yet do not improve acute renal dysfunction.
Kim HB; Shanu A; Wood S; Parry SN; Collet M; McMahon A; Witting PK
Free Radic Res; 2011 Sep; 45(9):1000-12. PubMed ID: 21726176
[TBL] [Abstract][Full Text] [Related]
6. Acetaminophen inhibits hemoprotein-catalyzed lipid peroxidation and attenuates rhabdomyolysis-induced renal failure.
Boutaud O; Moore KP; Reeder BJ; Harry D; Howie AJ; Wang S; Carney CK; Masterson TS; Amin T; Wright DW; Wilson MT; Oates JA; Roberts LJ
Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2699-704. PubMed ID: 20133658
[TBL] [Abstract][Full Text] [Related]
7. Curcumin reduces renal damage associated with rhabdomyolysis by decreasing ferroptosis-mediated cell death.
Guerrero-Hue M; García-Caballero C; Palomino-Antolín A; Rubio-Navarro A; Vázquez-Carballo C; Herencia C; Martín-Sanchez D; Farré-Alins V; Egea J; Cannata P; Praga M; Ortiz A; Egido J; Sanz AB; Moreno JA
FASEB J; 2019 Aug; 33(8):8961-8975. PubMed ID: 31034781
[TBL] [Abstract][Full Text] [Related]
8. Preventive effects of hyperbaric oxygen treatment on glycerol-induced myoglobinuric acute renal failure in rats.
Ayvaz S; Aksu B; Kanter M; Uzun H; Erboga M; Colak A; Basaran UN; Pul M
J Mol Histol; 2012 Apr; 43(2):161-70. PubMed ID: 22311626
[TBL] [Abstract][Full Text] [Related]
9. Heme protein-induced tubular cytoresistance: expression at the plasma membrane level.
Zager RA
Kidney Int; 1995 May; 47(5):1336-45. PubMed ID: 7637263
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of rhabdomyolysis-induced renal mitochondrial injury and apoptosis through suppression of Drp-1 translocation.
Tang WX; Wu WH; Qiu HY; Bo H; Huang SM
J Nephrol; 2013; 26(6):1073-82. PubMed ID: 23553524
[TBL] [Abstract][Full Text] [Related]
11. Curcumin-Loaded Nanoparticles Protect Against Rhabdomyolysis-Induced Acute Kidney Injury.
Chen X; Sun J; Li H; Wang H; Lin Y; Hu Y; Zheng D
Cell Physiol Biochem; 2017; 43(5):2143-2154. PubMed ID: 29065403
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of renal failure in rhabdomyolysis: the role of myoglobin.
Holt S; Moore K
Exp Nephrol; 2000; 8(2):72-6. PubMed ID: 10729745
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of L-carnitine on myoglobinuric acute renal failure in rats.
Aydogdu N; Atmaca G; Yalcin O; Taskiran R; Tastekin E; Kaymak K
Clin Exp Pharmacol Physiol; 2006; 33(1-2):119-24. PubMed ID: 16445710
[TBL] [Abstract][Full Text] [Related]
14. The influence of mannitol on myoglobinuric acute renal failure: functional, biochemical, and morphological assessments.
Zager RA; Foerder C; Bredl C
J Am Soc Nephrol; 1991 Oct; 2(4):848-55. PubMed ID: 1751788
[TBL] [Abstract][Full Text] [Related]
15. A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure.
Moore KP; Holt SG; Patel RP; Svistunenko DA; Zackert W; Goodier D; Reeder BJ; Clozel M; Anand R; Cooper CE; Morrow JD; Wilson MT; Darley-Usmar V; Roberts LJ
J Biol Chem; 1998 Nov; 273(48):31731-7. PubMed ID: 9822635
[TBL] [Abstract][Full Text] [Related]
16. Molecular Mechanisms and Novel Therapeutic Approaches to Rhabdomyolysis-Induced Acute Kidney Injury.
Panizo N; Rubio-Navarro A; Amaro-Villalobos JM; Egido J; Moreno JA
Kidney Blood Press Res; 2015; 40(5):520-32. PubMed ID: 26512883
[TBL] [Abstract][Full Text] [Related]
17. The role of myoglobin degradation in nephrotoxicity after rhabdomyolysis.
Zorova LD; Pevzner IB; Chupyrkina AA; Zorov SD; Silachev DN; Plotnikov EY; Zorov DB
Chem Biol Interact; 2016 Aug; 256():64-70. PubMed ID: 27329933
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cytochrome P450 2E1 and activation of transcription factor Nrf2 are renoprotective in myoglobinuric acute kidney injury.
Wang Z; Shah SV; Liu H; Baliga R
Kidney Int; 2014 Aug; 86(2):338-49. PubMed ID: 24717297
[TBL] [Abstract][Full Text] [Related]
19. Mechanism-based therapeutic approaches to rhabdomyolysis-induced renal failure.
Boutaud O; Roberts LJ
Free Radic Biol Med; 2011 Sep; 51(5):1062-7. PubMed ID: 21034813
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human erythropoietin reduces rhabdomyolysis-induced acute renal failure in rats.
Yang FL; Subeq YM; Chiu YH; Lee RP; Lee CJ; Hsu BG
Injury; 2012 Mar; 43(3):367-73. PubMed ID: 22209169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
